期刊
MOLECULAR MEDICINE REPORTS
卷 14, 期 2, 页码 1475-1482出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2016.5419
关键词
stromal cell-derived factor-1; C-X-C chemokine receptor type 4; chondrocytes; cartilage degradation; hypoxia; AMD3100
资金
- NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059142]
- NIH/National Center for Research Resources [P20RR024484]
- National Natural Science Foundation of China [81171676, 31271033, 81572098]
- Shanxi Province Science and Technology Research Projects [20150313012-6]
- Second Hospital of Shanxi Medical University [20140406]
- Shanxi Scholarship Council of China [2016-122]
Binding of the chemokine stromal cell-derived factor-1 (SDF-1) to its receptor C-X-C chemokine receptor type 4 (CXCR4) results in receptor activation and the subsequent release of matrix metalloproteinases (MMPs) that contribute to osteoarthritis (OA) cartilage degradation. As hypoxia is a defining feature of the chondrocyte microenvironment, the present study investigated the possible mechanism through which SDF-1 induces cartilage degradation under hypoxic conditions. To do this, OA chondrocyte cultures and patient tissue explants pretreated with the CXCR4 inhibitor, AMD3100 were incubated with SDF-1. It was identified that hypoxic conditions significantly elevated the expression of CXCR4 in osteoarthritic chondrocytes relative to normoxic conditions. Furthermore, SDF-1 elevated MMP-13 mRNA levels and proteinase activity. It also elevated the mRNA and protein levels of runt-related transcription factor 2, and induced the release of glycosaminoglycans and the inflammatory cytokine, interleukin-1 beta. By contrast, such changes did not occur to an appreciable degree in cells that were pretreated with AMD3100. The results of the present study demonstrate that even under hypoxic conditions, where CXCR4 expression is significantly elevated in chondrocytes, AMD3100 effectively blocks this receptor and protects chondrocytes from OA-induced catabolism, suggesting that the successful inhibition of CXCR4 may be an effective approach for OA treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据